Autopsy report · NCT01972854
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
Cause of deathNo reason given
Life of this trial
- Ran for about 3 years 5 months before it stopped.
- 92 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Glaukos Corporation
- Sponsor type
- Industry
- Conditions
- Keratoconus
- Interventions
- riboflavin solution; placebo solution; KXL System
- Participants
- 92
- Sites
- 11
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.